ASXL1 and coronary artery disorder: Nested case–control analyses of prospective cohorts, that together enrolled 4726 participants with coronary artery disease and 3529 controls, revealed that carriers of CHIP (DNMT3A, TET2 and ASXL1 mutations) have a risk of coronary artery disease that is substantially greater than controls (Table 3).